Dear Readers, Pharma Industrial India Magazine is happy to share its latest work i.e January-February 2024 issue with you. The issue brings standalone thought leadership from: Puunam G Kaushik, Deputy Managing Director and Chief Corporate Affairs, Meteoric Biopharmaceuticals Pvt. Ltd. ; Jashan Bhumkar, Director, Soujanya Lifesciences The issue also offers insight into various sectors through thought pieces from various industry pioneers and accelerators: Abhishek Batni, Consultant; Prashant VV, Consultant, Avalon Consulting; Sehgal Madhur, Head of Climate Solutions, Danfoss India Region; Do read the complete magazine here: https://lnkd.in/dwUQfr6q We hope you enjoy our work!!! #biotech #india #healthcare #manufacturing #drugsanddevelopment #equipment #treatment #biotechnology #globalpharma #pharmaceuticals #PharmaIndustrialIndia
Pharma Industrial India
Media Production
Pune, Maharashtra 5,386 followers
PROFESSIONAL MAGAZINE FOR PHARMA INDUSTRY SUPPLIERS AND LAB TECHNOLOGY
About us
PHARMA INDUSTRIAL INDIA is published by Omnimedia Publications India Pvt. Ltd. A 100% subsidiary of the European Omnimedia Group an International Publishing Company with leading technical magazines in the Energy, Construction, Tourism, Pharma and Life Sciences Industries, headquartered in Madrid, Spain. International Magazine for Pharmaceutical Industry Suppliers and Lab Technology. The Indian Pharma Industry expands rapidly and is already one of the largest pharmaceutical producers worldwide. This huge market requires technical equipment and services to compete in any phase of the pharmaceutical development, from the research stage to the final product.
- Website
-
http://www.pharmaindustrial-india.com/
External link for Pharma Industrial India
- Industry
- Media Production
- Company size
- 51-200 employees
- Headquarters
- Pune, Maharashtra
- Founded
- 2009
- Specialties
- Pharma Industry Magazine and Pharma Industrial India
Updates
-
Dr. Reddy's Russia arm, part of the global pharmaceutical company Dr. Reddy's Laboratories, has introduced Muslaxin (INN Ibuprofen 400 mg + Chlorzoxazone 500 mg), the first combination drug of NSAID and muscle relaxant that does not have generics in the Russian Federation. #healthcare #PharmaIndustrialIndia
-
Tiba Biotech has joined hands with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS). Jasdave Chahal #healthcare #PharmaIndustrialIndia
BARDA and Tiba Biotech to Develop Innovative Therapeutics Against Influenza - Global Pharma
pharmaindustrial-india.com
-
ProofPilot has announced the closing of its Series C #financing, led by Sopris Capital with Mitsui & Co., Ltd. (USA), Inc. participating. Chris Venezia Abinav Sankar #healthcare #PharmaIndustrialIndia
ProofPilot Announces Closing of its Series C Funding - Clinical Trials
pharmaindustrial-india.com
-
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. have announced that their investigational drug AHB-137 has received Breakthrough Therapy Designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China. #healthcare #PharmaIndustrialIndia
AusperBio Gets BTD for AHB-137 in Chronic Hepatitis B Treatment - Global Pharma
pharmaindustrial-india.com
-
Nusano Inc. has inked a #supplyagreement with Pharmalogic to provide a more efficient and reliable supply of critical #radioisotopes. James Beatty Chris Lowe #healthcare #PharmaIndustrialIndia
Nusano and PharmaLogic to Offer Current and Emerging Radiopharmaceuticals - Drug Discovery & Development
pharmaindustrial-india.com
-
Sudeep Pharma Pvt Ltd’s promoters have completed the acquisition of shares from their #jointventure partners – JRS PHARMA, regaining 100 percent ownership of the company. #healthcare #PharmaIndustrialIndia
Promoters of Sudeep Pharma Completes Acquisition from JRS Pharma - Global Pharma
pharmaindustrial-india.com
-
Sanofi has begun shipped its first influenza (flu) vaccines across the US in preparation for the 2024–25 flu season. Thomas Grenier #healthcare #PharmaIndustrialIndia
Sanofi Starts Shipping US Influenza Vaccines for 2024-25 - Global Pharma
pharmaindustrial-india.com
-
Alembic Pharmaceuticals Limited has secured final approval from the US Food and Drug Administration (US FDA) for its generic Bromfenac Ophthalmic Solution. #healthcare #PharmaIndustrialIndia
Alembic Pharma Gets USFDA Approval for Bromfenac Ophthalmic Solution - Drug Discovery & Development
pharmaindustrial-india.com
-
Pint Pharma has announced that the General Directorate of Medicines Supplies and Drugs (DIGEMID) in Peru has announced the approval of ORLADEYO (berotralstat) for prophylaxis of hereditary angioedema (HAE) attacks in adults and children 12 years and older. David Ricardo Munoz Guzman mauricio botero caicedo #healthcare #PharmaIndustrialIndia
Pint Pharma Announces Approval of ORLADEYO in Peru - Global Pharma
pharmaindustrial-india.com